We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Expression of CPI-17 in smooth muscle during embryonic development and in neointimal lesion formation.
- Authors
Jee In Kim; Young, Garbo D.; Li Jin; Somlyo, Avril V.; Eto, Masumi
- Abstract
Ca2+ sensitivity of smooth muscle (SM) contraction is determined by CPI-17, an inhibitor protein for myosin light chain phosphatase (MLCP). CPI-17 is highly expressed in mature SM cells, but the expression level varies under pathological conditions. Here, we determined the expression of CPI-17 in embryonic SM tissues and arterial neointimal lesions using immunohistochemistry. As seen in adult animals, the predominant expression of CPI-17 was detected at SM tissues on mouse embryonic sections, whereas MLCP was ubiquitously expressed. Compared with SM α-actin, CPI-17 expression doubled in arterial SM from embryonic day E10 to E14. Like SM α-actin and other SM marker proteins, CPI-17 was expressed in embryonic heart, and the expression was down-regulated at E17. In adult rat, CPI-17 expression level was reduced to 30% in the neointima of injured rat aorta, compared with the SM layers, whereas the expression of MLCP was unchanged in both regions. Unlike other SM proteins, CPI-17 was detected at non-SM organs in the mouse embryo, such as embryonic neurons and epithelium. Thus, CPI-17 expression is reversibly controlled in response to the phenotype transition of SM cells that restricts the signal to differentiated SM cells and particular cell types.
- Publication
Histochemistry & Cell Biology, 2009, Vol 132, Issue 2, p191
- ISSN
0948-6143
- Publication type
Academic Journal
- DOI
10.1007/s00418-009-0604-2